Robert W. Cook

Chief Tech/Sci/R&D Officer at CASTLE BIOSCIENCES, INC.

52 year

Health Technology

Consumer Services

Profile

Robert W.
Cook is currently the Senior Vice President-Research & Development at Castle Biosciences, Inc. He previously worked at Gen-Probe, Inc. as a Member-Product Transfer Department.
Dr. Cook holds a doctorate degree from Northwestern University and an undergraduate degree from Temple University (Pennsylvania).

Robert W. Cook active positions

Companies	Position	Start
CASTLE BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	2015-05-31

All active positions of Robert W. Cook

Former positions of Robert W. Cook

Companies	Position	End
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.	Corporate Officer/Principal	-

See the detail of Robert W. Cook's experience

Training of Robert W. Cook

Northwestern University	Doctorate Degree
Temple University (Pennsylvania)	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert W. Cook's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CASTLE BIOSCIENCES, INC.	Health Technology

Private companies	1
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.	Health Technology